Page 26 - Pharma Intelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics News provided by Share this article Share this article HANGZHOU, China and SHANGHAI, March 2, 2021 /PRNewswire/ -- Innoforce, a biopharmaceutical innovation enabling platform and PDMO (Partner Development and Manufacturing Organization), and dMed, a clinical CRO with strong presence in China and the US - the world's two largest pharmaceutical and drug development markets, have signed an agreement under which the two parties agreed to establish a partnership to identify, assess, and collaborate on the dev...

4 feb 2021 Skipta Donates Critical Online Media Support to U.S. COVID-19 Vaccine Education Campaign Contribution will help the Ad Council and COVID Collaborative amplify their national education effort for healthcare professionals in the U.S. around COVID-19 vaccine safety and effectiveness NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Skipta, part of Informa Pharma Intelligence and the leading social network of specialized online medical communities for verified healthcare professionals (HCPs), today announced its contribution to the Ad Council and COVID Collaborative’s national COVID-19 v...

Wednesday, 20 January 2021, 4:03 pm The year 2021 is set to become quite a year for the pharma companies leading the COVID-19 vaccine race, with significant revenues on the line. As some of the most significant players in the market, pharma giants Pfizer and Moderna are set for the lion's share of 2021 vaccine sales. According to data presented by Finaria.it, BioNTech-Pfizer and Moderna COVID-19 vaccines sales are expected to generate $14.7bn in revenue by 2023. Moderna COVID-19 Vaccine Sales Revenue to hit $3.5B in 2021 The call for COVID-19 vaccines and treatments has become louder than ev...

Press Release – Psychic Ventures Ltd The year 2021 is set to become quite a year for the pharma companies leading the COVID-19 vaccine race, with significant revenues on the line. As some of the most significant players in the market, pharma giants Pfizer and Moderna are set for the …The year 2021 is set to become quite a year for the pharma companies leading the COVID-19 vaccine race, with significant revenues on the line. As some of the most significant players in the market, pharma giants Pfizer and Moderna are set for the lion’s share of 2021 vaccine sales. According to data presen...

Michael Duck takes on new global executive VP - commercial development role at Informa Markets.